关于肉毒素治疗的经验教训从宫性 dystonia 患者绘制疾病的过程:一个试点研究
Harald Hefter1, Isabelle Schomaecker1, Max Schomaecker1
1Department of Neurology, University of Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.
Toxins
|July 28, 2023
概括
患者绘制的疾病严重程度图有助于识别对长期肉毒素 (BoNT) 治疗反应良好或不良的宫性 dystonia (CD) 患者. 用较低剂量治疗的早期响应者比使用高剂量治疗的二次不响应者表现得更好.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 宫 dystonia (CD) 是一种慢性神经运动障碍.
- 长期的肉毒毒素 (BoNT) 治疗是CD的常见治疗方法,但结果各不相同.
- 预测治疗反应对于优化患者护理至关重要.
研究的目的:
- 为了比较长期肉毒素 (BoNT) 治疗前后的宫性 dystonia 严重程度的过程.
- 为了确定与BoNT治疗的CD患者的良好或不良临床结果的指标.
主要方法:
- 招募了74名具有至少三次BoNT注射的异常性CD门诊患者.
- 患者绘制了从症状发作到BoNT治疗 (CoDB) 以及从BoNT发作到招募 (CoDA) 的疾病严重程度图表.
- 从患者病历中提取了人口统计和治疗数据.
主要成果:
- 最好的结果在患者中是明显的,快速的初始反应,用较低的BoNT剂量治疗和更少的制剂切换.
- 最糟糕的结果发生在二次不响应患者中,他们最初有所改善,但随后恶化,通常用更高的剂量治疗和频繁切换.
- 12名患者是初级不响应患者,17名患者显示二次不响应.
结论:
- 患者绘制的疾病严重程度图表可以有效地识别BoNT治疗的"黄金反应者".
- 这些图形表示也有助于检测难以治疗的初级和二级不响应者.
- 识别响应模式有助于量身定制和优化宫 dystonia 的长期 BoNT 治疗策略.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
705
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
705
Skeletal Muscle Relaxants: Therapeutic Uses
515
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
515
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Skeletal Muscle Relaxants: Adverse Effects
401
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
401
Depolarizing Blockers: Pharmocokinetics
353
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353
Depolarizing Blockers: Mechanism of Action
1.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K


